Health
SARS-CoV-2 Neucleocapside (N) protein is heavily glycosylated – News-Medical.Net
However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint server bioRxiv in August 2020 reveals the structure of this protein, a val…
Eight months into the COVID-19 pandemic, there is still no fully protective therapy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has infected millions worldwide. Vaccines are being worked on in a host of institutions and countries, mostly targeting the spike protein of the virus. However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint s…
-
General23 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News20 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
General16 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
General17 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire